Drug Discovery Seminars: An adaptable Drug Affinity Conjugate (ADAC) targeting CD40
Proof of Concept and Pharmaceutical profiling Sara Mangsbo, Uppsala University Abstract: Much attention has focused on developing CD40 directed agonistic monoclonal antibody therapy. Monoclonal antibodies targeting CD40 have been profiled for their epitope specificity and isotype in relation to their agonistic potential. Still, clinical impact relies on a well-balanced clinical efficacy versus target-mediated toxicity. As CD40-mediated […]